Plasma membrane receptors can be endocytosed through clathrindependent and clathrin-independent pathways. Here, we show that the epidermal growth factor (EGF) receptor (EGFR), when stimulated with low doses of EGF, is internalized almost exclusively through the clathrin pathway, and it is not ubiquitinated. At higher concentrations of ligand, however, a substantial fraction of the receptor is endocytosed through a clathrin-independent, lipid raft-dependent route, as the receptor becomes ubiquitinated. An ubiquitination-impaired EGFR mutant was internalized through the clathrin pathway, whereas an EGFR͞ubiquitin chimera, that can signal solely through its ubiquitin (Ub) moiety, was internalized exclusively by the non-clathrin pathway. Non-clathrin internalization of ubiquitinated EGFR depends on its interaction with proteins harboring the Ub-interacting motif, as shown through the ablation of three Ub-interacting motif-containing proteins, eps15, eps15R, and epsin. Thus, eps15s and epsin perform an important function in coupling ubiquitinated cargo to clathrin-independent internalization.internalization ͉ rafts ͉ caveolae ͉ ubiquitination ͉ ubiquitin-interacting motif U biquitination is a posttranslational modification whereby substrate proteins are conjugated to a short highly conserved peptide, ubiquitin (Ub), through the action of Ub ligases (E3 enzymes). Polyubiquitination, in which a chain of Ub is appended, targets proteins to proteasomal degradation (1). However, when a single Ub moiety is appended (monoubiquitination), the modification functions as a signaling device through interactions with intracellular proteins harboring Ub-binding domains, such as the Ub-interacting motif (UIM) (2). In yeast, monoubiquitination has been known to act as an internalization signal for quite some time (3). In mammals, however, this connection has remained more elusive.We are interested in the mechanisms of internalization of receptor tyrosine kinases and, in particular, the epidermal growth factor receptor (EGFR). The EGFR is monoubiquitinated at multiple sites (4) through the action of the E3 enzyme Cbl. Although there is consensus on the function of Cbl and receptor ubiquitination in intracellular sorting of the EGFR, their role in the internalization step of endocytosis is less clear (5, 6). To gain insight into this issue, we generated a chimera in which the extracellular and transmembrane domains of the EGFR are fused to a mutant Ub (Ubmut), unable to form polyUb chains (EGFR͞Ubmut). With this chimera, we showed that ubiquitination is sufficient for internalization (4). The present studies were undertaken to elucidate the molecular mechanisms through which receptor ubiquitination directs internalization. Materials and MethodsTransfection and Biochemical Studies. Transfections were performed by using Lipofectamine or Oligofectamine (Invitrogen). For biochemical experiments, cells were serum-starved and then stimulated with EGF (100 ng͞ml, unless otherwise indicated) at 37°C. Lysis, immunoprecipitation, and immunoblot...
Macrophage‐derived chemokine (MDC)/CCL22 is a CC chemokine active on dendritic cells (DC), NK cells and Th2 lymphocytes. The present study was aimed at comprehensively investigating MDC production in vitro and in vivo. DC were the most potent producers of MDC among leukocytes tested. Endothelial cells did not produce MDC under a variety of conditions. Signals that induce maturation (lipopolysaccharide, IL‐1, TNF, CD40 ligand, recognition of bacteria and yeast) dramatically augmented MDC production, and dexamethasone and vitamin D3 blocked it. Prostaglandin E2, which blocked the acquisition of IL‐12 production and the capacity to promote Th1 generation, did not affect MDC production. Using mass spectrometry‐based techniques, DC supernatants were found to contain N‐terminally truncated forms of MDC [MDC(3–69), MDC(5–69) and MD(C7–69)] as well as the full‐length molecule. In vivo, CD1a+, CD83+, MDC+ DC were found in reactive lymph nodes, and in Langerhans' cell histiocytosis. Skin lesions of atopic dermatitis patients showed that CD1a+ or CD1b+ DC, and DC with a CD83+ phenotype were responsible for MDC production in this Th2‐oriented disorder. Thus, DC are the predominant source of MDC in vitro and in vivo under a variety of experimental and clinical conditions. Processing of MDC to MDC(3–69) and shorter forms which do not recognize CCR4 is likely to represent a feedback mechanism of negative regulation.
A major obstacle for the development of effective immunotherapy is the ability of tumors to escape the immune system. The possibility to kill tumor cells because they are recognized as infected rather than as malignant could help overcome immune escape mechanisms. Here we report a conceptually new approach of cancer immunotherapy based on in vivo infection of tumors and killing of infected tumor cells. Attenuated but still invasive, Salmonella typhimurium can be successfully exploited to invade melanoma cells that can present antigenic determinants of bacterial origin and become targets for antiSalmonella-specific T cells. However, to fully appreciate the anticancer therapeutic properties of S. typhimurium, tumorbearing mice need to be vaccinated against S. typhimurium before intratumoral Salmonella injection. Tumor infection when coupled to anti-Salmonella vaccination leads to 50% to 100% tumor-free mice with a better outcome on larger tumors. Invasive Salmonella also exert an indirect toxic effect on tumor cells through the recruitment of inflammatory cells and the cross-presentation of tumor antigens, which allow induction of tumor-specific immune response. This is effective in retarding the growth of untreated established distant tumors and in protecting the mice from subsequent tumor challenges. (Cancer Res 2005; 65(9): 3920-7)
Taken together, these in vivo and in vitro findings support a model whereby HIV encephalitis is sustained by virus replication in microglial cells, a process amplified by recruitment of mononuclear cells via HIV-induced MCP-1.
As originally demonstrated for the interleukin 1 (IL-1) type II receptor, some primary proinflammatory cytokines from the IL-1 and tumor necrosis factor families are regulated by decoy receptors that are structurally incapable of signaling. Here we report that concomitant exposure to proinflammatory signals and IL-10 generates functional decoy receptors in the chemokine system. Inflammatory signals, which cause dendritic cell (DC) maturation and migration to lymphoid organs, induce a chemokine receptor switch, with down-regulation of inflammatory receptors (such as CCR1, CCR2, CCR5) and induction of CCR7. Concomitant exposure to lipopolysaccharide (LPS) and IL-10 blocks the chemokine receptor switch associated with DC maturation. LPS + IL-10-treated DCs showed low expression of CCR7 and high expression of CCR1, CCR2 and CCR5. These receptors were unable to elicit migration. We provide evidence that uncoupled receptors, expressed on LPS + IL-10-treated cells, sequester and scavenge inflammatory chemokines. Similar results were obtained for monocytes exposed to activating signals and IL-10. Thus, in an inflammatory environment, IL-10 generates functional decoy receptors on DC and monocytes, which act as molecular sinks and scavengers for inflammatory chemokines.
In vitro FRAP is a widely applicable approach to dissecting the molecular bases of the interaction of a macromolecule with an insoluble cellular scaffold. The combination of in vitro fluorescence recovery after photobleaching with additional fluorescence-based assays in vitro can be used to unveil mechanism, stoichiometry, and kinetic parameters of a macromolecular interaction, all of which are important for modeling protein interaction networks.
Budding yeast Sgt1 is required for kinetochore assembly, and its homologues have a role in cAMP signalling in fungi and pathogen resistance in plants. The function of mammalian Sgt1 is unknown. We report that RNA interference‐mediated depletion of Sgt1 from HeLa cells causes dramatic alterations of the mitotic spindle and problems in chromosome alignment. Cells lacking Sgt1 undergo a mitotic delay due to activation of the spindle checkpoint. The checkpoint response, however, is significantly weakened in Sgt1‐depleted cells, and this correlates with a dramatic reduction in kinetochore levels of Mad1, Mad2 and BubR1. These effects are explained by a problem in kinetochore assembly that prevents the localization of Hec1, CENP‐E, CENP‐F, CENP‐I, but not CENP‐C, to mitotic kinetochores. Our studies implicate Sgt1 as an essential protein and a critical assembly factor for the mammalian kinetochore, and lend credit to the hypothesis of a kinetochore assembly pathway that is conserved from yeast to man.
Irreversible modifications in tertiary structure, surface hydrophobicity, and association state of β-lactoglobulin were studied after exposure to high pressure (600 and 900 MPa) of solutions of the protein at neutral pH and at different concentrations. Only minor irreversible structural modifications were evident even for treatments as intense as 15 min at 900 MPa. The occurrence of irreversible modifications was time-progressive at 600 MPa but was complete within 2 min at 900 MPa. The irreversibly modified protein was soluble, but some covalent aggregates were formed. Formation of aggregates increased with increasing protein concentration and was prevented by blocking the free thiol moiety in each β-lactoglobulin monomer. Results are discussed in light of their practical relevance, and a unifying denaturation mechanism is envisaged for β-lactoglobulin. In the proposed mechanism, release of monomers represents one of the earliest events, while association of transiently modified monomers stabilizes the denatured forms of the protein. Keywords: β-Lactoglobulin; high-pressure treatments; protein structure; protein association
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.